| NDC Code | 68001-517-36 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-517-36) / 5 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 68001-517 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Fosaprepitant |
|---|
| Non-Proprietary Name | Fosaprepitant |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20210823 |
|---|
| End Marketing Date | 20240731 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA212309 |
|---|
| Manufacturer | BluePoint Laboratories |
|---|
| Substance Name | FOSAPREPITANT DIMEGLUMINE |
|---|
| Strength | 150 |
|---|
| Strength Unit | mg/5mL |
|---|
| Pharmacy Classes | Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
|---|